Luvalis Pharma ApS

CVR 45786684 · Private limited company (ApS) · Active · High risk

Luvalis Pharma ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 3.4% over the next 12 months, which is 2.4 times the average for Danish companies. CEO: Jonas Hammershaimb Mosbech, Bo Yde Svendsen.

Bankruptcy risk for Luvalis Pharma ApS

3.4%
probability of bankruptcy within 12 months
High risk

2.4 × the average (1.41%) · higher risk than 88% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)1 yrs · bankruptcy rate 21.6%2.5×
Published annual reports0 · bankruptcy rate 16.7%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×

Reduces the risk

Number of CEOs2 · bankruptcy rate 5.7%0.65×
Has a boardYes · bankruptcy rate 6.0%0.68×
Registered owners3 · bankruptcy rate 6.2%0.71×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
45786684
Status
Active
Company type
Private limited company (ApS)
Founded
(1 years)
Address
c/o Legaldesk.dk ApS, Njalsgade 21F, 2.
2300 København S
Municipality
København
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 0
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address951
Going-concern uncertaintyNo

Management, owners and auditor

RoleNameFromTo
CEOJonas Hammershaimb MosbechCurrent
CEOBo Yde SvendsenCurrent
BoardMikkel GeertsenCurrent
BoardJonas Hammershaimb MosbechCurrent
BoardBo Yde SvendsenCurrent
Owner (33%)Mixin ApSCurrent
Owner (33%)Ragdoll Invest ApSCurrent
Owner (33%)BOSV ApSCurrent
FounderMixin ApSCurrent
FounderRagdoll Invest ApSCurrent
FounderBOSV ApSCurrent

The CEOs' other companies

Jonas Hammershaimb Mosbech – 4 other companies

Bo Yde Svendsen – 3 other companies

Address history (1 moves)

c/o Legaldesk.dk ApS, Njalsgade 21F, 2., 2300 København S
c/o Bo Svendsen, Højstrupvej 13, st., 2720 Vanløse

Other companies at the same address

Similar companies in København

Questions and answers about Luvalis Pharma ApS

Has Luvalis Pharma ApS gone bankrupt?

No, Luvalis Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Luvalis Pharma ApS?

Our model estimates a bankruptcy risk of 3.4% over the next 12 months (high risk), which is 2.4 times the average for Danish companies.

Who is the CEO of Luvalis Pharma ApS?

Jonas Hammershaimb Mosbech, Bo Yde Svendsen are the CEOs of Luvalis Pharma ApS.

When was Luvalis Pharma ApS founded?

Luvalis Pharma ApS was founded on 23 July 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.